Effects of Different Methods Used to Take Blood Samples on Blood Glucose Measurements

July 23, 2020 updated by: Eda Ergin, Izmir Bakircay University

Aims and Objectives: The purpose of this study is to compare whether or not there is a difference between venous and capillary blood samples in blood glucose measurements and investigate the effects of different aseptic methods used in skin cleaning before collecting blood samples on measurement results.

Background: Capillary blood glucose measurement is a frequently used measurement method in both clinical environments and the home environment. However, several different aseptic techniques are used in collecting blood samples for glucose measurement.

Design and Methods: This was a quasi-experimental study that was conducted with 109 patients who visited the blood collection unit of a University Hospital located in Western Turkey for 75 gr OGTT between November 2017 and April 2018. The capillary first and second blood drop values taken from the patients after fasting and at two hours following OGTT and capillary and venous blood glucose values were compared.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The data were collected by the researcher at the waiting room of the blood collection unit at a close distance to the lavatory. A nurse working at the venous blood sample unit collected fasting and 2 hours after OGTT venous blood samples from the individuals who arrived at the blood collection unit for 75 gr OGTT. All venous blood and capillary blood samples were obtained in a shorter time than 5 minutes. In this study, capillary blood samples were taken from the same participant in four different ways:

  • As the first intervention, the middle finger of the individuals agreeing to participate in the study was rubbed and wiped with a cotton infused with 70% alcohol, and 10 seconds were given for it to dry. Afterwards, by perforating the finger with a lancet, firstly the first blood drop glucose value and then the second blood drop glucose value were measured.
  • As the second intervention, after ensuring that the individuals washed their hands with soap at the lavatory of the blood collection unit and dried their hands with paper towels, the middle finger of the right hand was rubbed, perforated with a lancet, and firstly the first blood drop glucose value and then the second blood drop glucose value were measured.
  • As the third intervention, for the individuals whose hands had been washed, the middle finger of the left hand was rubbed and wiped with 70% alcohol-infused cotton, and 10 seconds were given for it to dry. The finger was perforated with a lancet and the first and second blood drop glucose values were recorded.
  • As the fourth intervention, 2 hours after the individuals drank a beverage containing 75 gr of sugar for OGTT, in a state where their hands had been washed, the finger was wiped with 70% alcohol, left to dry, perforated with a lancet, and the first and second blood drop glucose values were measured and recorded

Study Type

Interventional

Enrollment (Actual)

109

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • İzmir, Turkey, 35665
        • İzmir Bakırçay University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • who had both upper extremities,
  • good capillary saturation,
  • blood glucose monitoring requests for OGTT,
  • who were fasting for 8-12 hours before giving blood,
  • who had requests for 75 gr sugar loading
  • who volunteered to participate in the study.

Exclusion Criteria:

  • who refused to participate in the study,
  • whose capillary blood glucose could not be looked at after sugar loading.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
The data were collected by the researcher at the waiting room of the blood collection unit at a close distance to the lavatory. The capillary first and second blood drop values taken from the patients after fasting and at two hours following OGTT and capillary and venous blood glucose values were compared.
The patient's finger was wiped with alcohol, left to dry, and the first and second blood drops were read The patient was asked to wash their hands, their finger was perforated with a strip, and the first and second blood drops were read The finger of the patient whose hands had been washed was wiped with alcohol, left to dry, and the first and second blood drops were read Venous blood was collected for blood sugar measurement 2 hours after the patient had a beverage containing 75 gr sugar for OGTT The patient was ensured to wash their hands, their finger was wiped with alcohol, and the first and second blood drop glucose values were measured and recorded
Other Names:
  • capillary blood samples were taken from the same participant in four different ways

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Information Form
Time Frame: at 6-month
10 questions on the sociodemographic characteristics of the participants such as age, sex, height-weight, status of DM diagnosis in the family, status of having another chronic disease and status of smoking and alcohol consumption
at 6-month
Data Record Form
Time Frame: at 6-month
The individuals' venous blood glucose values, capillary fasting blood glucose first and second blood drop values measured with aseptic techniques and the first and second blood drop values of the venous and capillary blood glucose 2 hours after OGTT were recorded into a "Data Record Form". As the glucometer device in the study, Roche's Accu-Chek® Performa Nano brand measurement device was used
at 6-month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 27, 2017

Primary Completion (Actual)

December 5, 2017

Study Completion (Actual)

April 30, 2018

Study Registration Dates

First Submitted

July 14, 2020

First Submitted That Met QC Criteria

July 23, 2020

First Posted (Actual)

July 24, 2020

Study Record Updates

Last Update Posted (Actual)

July 24, 2020

Last Update Submitted That Met QC Criteria

July 23, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • Eda ERGIN, PhD,RN
  • Ayten Zaybak (Other Identifier: Ege University, Turkey, İzmir)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Glucose, Low

Clinical Trials on capillary blood samples

3
Subscribe